Tenpoint Therapeutics Launches YUVEZZI Direct-to-Consumer Campaign

Gretchyn Bailey

Super Moderator
Staff member
Jan 18, 2001
3,789
1,274
113
School/Org
ODwire
City
Lansdale
State
PA
More info out there for patients about presbyopia treatment options.
—Gretchyn

LONDON, U.K. and WARREN, NJ, June 29, 2026—Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced the launch of Friends of the Presbyopians, its first national consumer campaign for YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, the first and only dual-agent, once-daily prescription eye drop approved by the U.S. Food and Drug Administration (FDA) for the treatment of presbyopia.

Presbyopia is the gradual loss of close-up vision that typically begins around age 45 and affects about 128 million adults in the U.S. and about 2 billion people globally.1-3 Presbyopia can make simple things harder, like reading, texting, or checking labels at the store.1

The campaign introduces an original cast of hand-crafted puppets that shine a light on the everyday workarounds people with presbyopia often rely on to manage their blurry close-up vision. From a restaurant menu tired of being held at arm’s length or blinded with a flashlight, to a smartphone weary of being squinted at, to a pair of reading glasses exhausted from being dropped or misplaced, the puppets share how they feel about being overused, tossed around and relied on day after day. Through their humorous complaints, Friends of the Presbyopians suggests there may be a better way to manage presbyopia with Yuvezzi.

“We are very excited to launch our national consumer campaign for Yuvezzi which represents the next phase of our launch strategy as Tenpoint continues to build momentum in the market,” said Henric Bjarke, Chief Executive Officer of Tenpoint Therapeutics. “For millions of adults, blurry close-up vision shows up in frustrating ways every day. Through this campaign, we hope to spark conversations about the impact blurry close-up vision can have on important daily life tasks and encourage people to learn more about Yuvezzi.”

1782765117101.png


To create the distinctive characters at the heart of the campaign, Tenpoint Therapeutics partnered with award-winning filmmaker Spencer Susser and a team of puppet designers and fabricators, including veteran puppeteer Ben Bayouth, a finalist on Jim Henson’s Creature Shop Challenge. Brought to life through a blend of handcrafted puppetry and animatronics, the puppets offer a playful and unexpected perspective on the everyday workarounds people implement because of presbyopia. The campaign is launching nationwide across digital and social channels.

“When we listened to people with presbyopia, what stood out wasn't a single moment of blurry close-up vision, it was all the daily adjustments that add up over time: the squinting, the arm trombone, and the constant search for misplaced reading glasses,” said Carol Kearney, Chief Commercial Officer of Tenpoint Therapeutics. “With Friends of the Presbyopians, we wanted to bring those familiar moments to life with humor, warmth, and a touch of nostalgia. By giving everyday objects a voice, we're inviting people with presbyopia to see this stage of life differently, recognize that blurry close-up vision doesn’t have to be something they simply accept, and to talk with their eye care professional about whether Yuvezzi may be right for them.”

Yuvezzi can be used on its own instead of reading glasses, or with contacts or glasses used to see far away, helping support clear near vision during the most visually demanding parts of the day.*4 In medical studies, Yuvezzi provided up to 8 continuous hours of improved close-up vision.**4 As soon as 30 minutes after taking Yuvezzi, some people could clearly read at least 3 more lines on an eye chart in low light without losing distance vision.

The most common side effects of Yuvezzi in medical studies were headache, impaired vision and, upon instillation, eye pain and/or eye irritation. Patients should not use Yuvezzi if they are allergic to any of its ingredients or if you currently have inflammation of the iris (iritis). Most side effects were generally mild, didn’t last long, and went away on their own.4

Patients can fill prescriptions for Yuvezzi nationwide through our e-pharmacy partner PHILRx or any local retail pharmacy of their choice. To find an eye doctor that can determine if Yuvezzi is right for you visit: https://www.yuvezzi.com/presbyopia-specialist-finder.

*If you wear contact lenses, remove them before using Yuvezzi. Wait at least 10 minutes after using Yuvezzi before you put them back in your eyes.

**About half of people in medical studies could read close up at hour 8.